Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies

E Carnero Contentti, J Correale - Journal of neuroinflammation, 2021 - Springer
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Hope for patients with neuromyelitis optica spectrum disorders—from mechanisms to trials

SJ Pittock, A Zekeridou, BG Weinshenker - Nature Reviews Neurology, 2021 - nature.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …

Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders

M Bonnan, R Valentino, S Debeugny… - Journal of Neurology …, 2018 - jnnp.bmj.com
Introduction Severe attacks of neuromyelitis optica spectrum disorder (NMO-SD) are
improved by plasma exchange (PLEX) given as an adjunctive therapy. Initial studies failed …

Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses

I Kleiter, A Gahlen, N Borisow, K Fischer… - Annals of …, 2016 - Wiley Online Library
Objective Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and
leave residual deficits. Here, we analyzed the frequency, sequence, and efficacy of …

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)

C Trebst, S Jarius, A Berthele, F Paul, S Schippling… - Journal of …, 2014 - Springer
Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions

I Kleiter, A Gahlen, N Borisow, K Fischer… - Neurology …, 2018 - AAN Enterprises
Objective To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma
exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica …